+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
ID07051811

Study to Test Safety and Effectiveness of a Single-Use Ultrasound Ablation Catheter for Treating Primary Hypertension in Adults Aged 18 to 75

Led by Lepu Medical Technology (Beijing) Co., Ltd. · Updated on 2025-07-04

213

Participants Needed

18

Research Sites

104 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and effectiveness of a single-use intravascular ultrasound ablation catheter and system for treating primary hypertension. This multicenter, prospective, randomized controlled trial compares this new treatment with standard care to determine if it better reduces blood pressure. Participants have primary hypertension and are on specific medication regimens before joining the study. Participants will first enter a screening phase with a 4-week run-in period using a standardized medication regimen involving a combination of angiotensin II receptor blocker ARB and calcium channel blocker CCB, with possible addition of a diuretic. Those meeting blood pressure criteria will be randomized in a 21 ratio to either receive the ultrasound ablation therapy or only renal artery angiography. Both groups will continue the medication regimen for 6 months after the procedure, with medication adjustments allowed based on blood pressure. During the study, participants will have their office and 24-hour ambulatory blood pressure monitored at multiple timepoints, along with tracking of medication use and any safety or adverse events. The primary outcome is the change in 24-hour average ambulatory systolic blood pressure at 6 months. Secondary outcomes include various blood pressure measures and medication adjustments. The study will last at least 6 months post-procedure, with follow-up visits to assess health and treatment effects.

CONDITIONS

Brief Title

To Evaluate the Safety and Efficacy of a Single-Use IVUS Ablation for Primary Hypertension

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here